Chromition Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- Grant
- Latest Deal Amount
- $1.26M
- Investors
- 5
Chromition General Information
Description
Developer of a digital histopathology screening platform intended to detect cancer in a single tissue biopsy. The company's platform provides a digital multi-colored image of the tissue biopsy which is analysed by a software that assists the clinical decision making process of diagnosis, enabling physicians to take targeted decisions regarding treatments and have high success rate of patient outcome.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
- Greenheys Building
- Pencroft Way
- Manchester M15 6JJ
- England, United Kingdom
Chromition Timeline
Chromition Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 27-Nov-2018 | $1.26M | 00000 | Completed | Generating Revenue | |
| 6. Grant | 23-Oct-2018 | 000.00 | 00000 | Completed | Generating Revenue | |
| 5. Early Stage VC | 21-Dec-2017 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 4. Early Stage VC | 20-Dec-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
| 3. Seed Round | 01-Apr-2016 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Accelerator/Incubator | $158K | Completed | Startup | |||
| 1. Seed Round | 31-Jul-2015 | $158K | $158K | 00000 | Completed | Startup |
Chromition Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| A Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| A Ordinary | 2,333 | $0.013389 | $100.42 | $100.42 | 1x | $100.42 | 13.68% | |
| Ordinary | 1,990 | $0.013389 | $68.31 | $68.31 | 1x | $68.31 | 11.67% |
Chromition Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark McCairn Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Michael Turner Ph.D | Co-Founder, Board Member, Scientific & Technical Advisor |
Chromition Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Mark Frost | Chromition | Chairman | 000 0000 |
| Mark McCairn Ph.D | Chromition | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Michael Turner Ph.D | Chromition | Co-Founder, Board Member, Scientific & Technical Advisor | 000 0000 |
| Perry van Rijsingen | Self | Board Member & Strategic Advisor | 000 0000 |
Chromition Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| SBRI Healthcare | Government | 000 0000 | 000000 0 | ||
| Horizon 2020 | Government | 000 0000 | 000000 0 | ||
| Mercia Asset Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
| MTI Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| NETPark Incubator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |